Foyston, Gordon, & Payne Inc Novo Nordisk A S Transaction History

Foyston, Gordon, & Payne Inc

$392 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $779,060 - $941,734	-8,368 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$67.66 - $84.76 $977,551 - $1.22 Million	-14,448 Reduced 63.32%	8,368 $701,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $402 - $454	-6 Reduced 0.03%	22,816 $1.54 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $1,661 - $1,918	-26 Reduced 0.11%	22,822 $1.59 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $3,821 - $4,213	-60 Reduced 0.26%	22,848 $1.59 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $4,624 - $5,367	-79 Reduced 0.34%	22,908 $1.5 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $2,720 - $3,562	55 Added 0.24%	22,987 $1.38 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $1.79 Million - $2.09 Million	-35,945 Reduced 61.05%	22,932 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $72,213 - $81,160	-1,519 Reduced 2.52%	58,877 $3.04 Million
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $46,181 - $51,787	-987 Reduced 1.61%	60,396 $3.08 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $9,596 - $10,894	-207 Reduced 0.34%	61,383 $3.21 Million
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $24,425 - $27,783	-588 Reduced 0.95%	61,590 $2.84 Million
Q3 2018 Nov 02, 2018	BUY	$46.76 - $51.24 $29,645 - $32,486	634 Added 1.03%	62,178 $2.93 Million
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $1.99 Million - $2.27 Million	-45,004 Reduced 42.24%	61,544 $2.84 Million
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $142,754 - $171,164	-2,944 Reduced 2.69%	106,548 $5.25 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $2.95 Million - $3.33 Million	-61,980 Reduced 36.15%	109,492 $5.88 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $2.34 Million - $2.8 Million	56,941 Added 49.72%	171,472 $8.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	114,531	114,531 $4.91 Million

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$2.07 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.47 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.47 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.37 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.25 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.

Account